#3 - Dr Prash Puspanathan: The Psychiatric Potential Of Psychedelic Medicine

Dr. Prash Puspanathan (aka Dr. Prash P) has had an interesting pathway to the field of psychiatry. It was his initial interest in psychedelic medicine that prompted his curiosity into the world of the mind, leading him to study Psychiatry to further his interest in psychedelic medicine and its therapeutic potential. Prash has been a medical doctor at the Alfred Hospital where he has most recently held the position of Neuropsychiatry Fellow. He has been an ongoing advocate for medicine-assisted therapies and has spoken at events through Australia and at conferences worldwide. He started and managed Psychonauts Onymous, Australia’s first monthly gathering of multidisciplinary professionals to discuss current research in the field of psychedelics.
Dr. Prash Puspanathan (aka Dr. Prash P) has had an interesting pathway to the field of psychiatry. It was his initial interest in psychedelic medicine that prompted his curiosity into the world of the mind, leading him to study Psychiatry to further his interest in psychedelic medicine and its therapeutic potential. Prash has been a medical doctor at the Alfred Hospital where he has most recently held the position of Neuropsychiatry Fellow. He has been an ongoing advocate for medicine-assisted therapies and has spoken at events through Australia and at conferences worldwide. He started and managed Psychonauts Onymous, Australia’s first monthly gathering of multidisciplinary professionals to discuss current research in the field of psychedelics. He is also the CEO of Australia’s first dedicated Cryptocurrency brokerage, Caleb & Brown.


Topics Covered:
  • The spectrum of mental illness
  • Limitation of causes and diagnosing mental illness, 
  • Brain and mind disassociation
  • The rewiring effects and new pathways of thinking that psychedelic medicine offers
  • What empirical evidence we have for the psychedelic space
  • Breaking away from the mould of using the word “drug”
  • Recalling trauma through MDMA
  • The difficulty in using language to explain a psychedelic experience 
  • The importance of integration
  • Risks associated with psychedelics - recreational vs. therapeutic and short and long term implications


Tommy Moore